Compare AUPH & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUPH | DRD |
|---|---|---|
| Founded | 1993 | 1895 |
| Country | Canada | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.3B |
| IPO Year | 1999 | N/A |
| Metric | AUPH | DRD |
|---|---|---|
| Price | $15.75 | $30.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $17.25 | ★ $27.50 |
| AVG Volume (30 Days) | ★ 1.6M | 457.3K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | N/A | ★ 68.66 |
| EPS | 0.55 | ★ 1.46 |
| Revenue | $265,808,000.00 | ★ $443,674,785.00 |
| Revenue This Year | $21.22 | $18.10 |
| Revenue Next Year | $15.40 | $25.92 |
| P/E Ratio | $28.81 | ★ $21.54 |
| Revenue Growth | 20.62 | ★ 26.26 |
| 52 Week Low | $6.55 | $8.38 |
| 52 Week High | $16.48 | $33.31 |
| Indicator | AUPH | DRD |
|---|---|---|
| Relative Strength Index (RSI) | 57.76 | 58.42 |
| Support Level | $15.15 | $28.04 |
| Resistance Level | $16.03 | $33.31 |
| Average True Range (ATR) | 0.50 | 1.31 |
| MACD | -0.12 | 0.15 |
| Stochastic Oscillator | 57.02 | 51.99 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.